- Home
- DSGN vs PLG Comparison
DSGN vs PLG Comparison
Compare DSGN & PLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- PLG
- Stock Information
- Founded
- DSGN 2017
- PLG 2000
- Country
- DSGN United States
- PLG Canada
- Employees
- DSGN N/A
- PLG N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- PLG
- Sector
- DSGN Health Care
- PLG
- Exchange
- DSGN Nasdaq
- PLG Nasdaq
- Market Cap
- DSGN 208.9M
- PLG 217.6M
- IPO Year
- DSGN 2021
- PLG N/A
- Fundamental
- Price
- DSGN $6.54
- PLG $2.78
- Analyst Decision
- DSGN
- PLG
- Analyst Count
- DSGN 0
- PLG 0
- Target Price
- DSGN N/A
- PLG N/A
- AVG Volume (30 Days)
- DSGN 173.8K
- PLG 3.3M
- Earning Date
- DSGN 11-06-2025
- PLG 11-25-2025
- Dividend Yield
- DSGN N/A
- PLG N/A
- EPS Growth
- DSGN N/A
- PLG N/A
- EPS
- DSGN N/A
- PLG N/A
- Revenue
- DSGN N/A
- PLG N/A
- Revenue This Year
- DSGN N/A
- PLG N/A
- Revenue Next Year
- DSGN N/A
- PLG N/A
- P/E Ratio
- DSGN N/A
- PLG N/A
- Revenue Growth
- DSGN N/A
- PLG N/A
- 52 Week Low
- DSGN $2.60
- PLG $0.99
- 52 Week High
- DSGN $7.77
- PLG $3.07
- Technical
- Relative Strength Index (RSI)
- DSGN 54.51
- PLG 78.59
- Support Level
- DSGN $5.88
- PLG $2.43
- Resistance Level
- DSGN $7.59
- PLG $3.07
- Average True Range (ATR)
- DSGN 0.51
- PLG 0.24
- MACD
- DSGN -0.06
- PLG 0.05
- Stochastic Oscillator
- DSGN 37.42
- PLG 79.63
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About PLG Platinum Group Metals Ltd. (Canada)
Platinum Group Metals Ltd is the operator of the Waterberg Project, a bulk underground PGM deposit located in South Africa. Waterberg was discovered by Platinum Group and is being jointly developed with Implats, the Japan Oil, Gas and Metals National Corporation (JOGMEC) and Hanwa Co. Ltd. Waterberg has the potential to be a large-scale, low-cost producer of palladium, platinum, rhodium, and gold. Geographically, it operates in Canada and South Africa.